VMD · NASDAQ
Viemed Healthcare (VMD) Stock Price & Fundamentals
Viemed Healthcare (VMD) closed at $1,025.59 on Oct 9, 2026, down 0.48% from the previous close of $1,030.52.
Share price, past year
1Y +5.71%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,025.59 |
| Sep 30, 2026 | $1,020.41 |
| Aug 31, 2026 | $1,008.84 |
| Jul 31, 2026 | $1,070.74 |
| Jun 30, 2026 | $1,119.30 |
| May 29, 2026 | $1,075.24 |
| Apr 30, 2026 | $997.36 |
| Mar 31, 2026 | $952.51 |
| Feb 27, 2026 | $918.95 |
| Jan 30, 2026 | $938.37 |
| Dec 31, 2025 | $962.73 |
| Nov 28, 2025 | $1,006.34 |
| Oct 31, 2025 | $1,031.49 |
Key statistics
- Market cap
- $39.06B
- P/E (TTM)
- 2,848.9
- EPS (TTM)
- $0.36
- Revenue (TTM)
- $301.61M
- Net income (TTM)
- $14.50M
- Shares outstanding
- 38.1M
- Dividend yield
- —
- 52-week range
- $901.30 – $1,119.55
Viemed Healthcare's market cap is $39.06B, based on a share price of $1,025.59 and 38.1M shares outstanding as of Jun 30, 2026.
Financials
Viemed Healthcare reported revenue of $270.28M for fiscal 2025, up 20.52% from fiscal 2024.
Viemed Healthcare earned net income of $14.93M in fiscal 2025, a net margin of 5.5%.
Fiscal 2025 revenue was the highest in the 8 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $270.28M | +20.5% | $14.93M | 5.5% | $0.37 | $11.93M |
| FY2024ended Dec 31, 2024 | $224.26M | +22.5% | $11.27M | 5.0% | $0.28 | $1.32M |
| FY2023ended Dec 31, 2023 | $183.01M | +31.8% | $10.24M | 5.6% | $0.25 | $19.12M |
| FY2022ended Dec 31, 2022 | $138.83M | +18.6% | $6.22M | 4.5% | $0.16 | $4.85M |
| FY2021ended Dec 31, 2021 | $117.06M | −10.9% | $9.13M | 7.8% | $0.22 | $2.75M |
| FY2020ended Dec 31, 2020 | $131.31M | +63.6% | $31.53M | 24.0% | $0.78 | $22.07M |
| FY2019ended Dec 31, 2019 | $80.26M | +24.5% | $8.53M | 10.6% | $0.21 | $5.70M |
| FY2018ended Dec 31, 2018 | $64.46M | — | $9.51M | 14.8% | $0.24 | $16.25M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $78.10M | $2.76M | $0.07 |
| Q1 FY2026ended Mar 31, 2026 | $75.41M | $2.58M | $0.06 |
| Q4 FY2025ended Dec 31, 2025 | $76.18M | $5.64M | $0.14 |
| Q3 FY2025ended Sep 30, 2025 | $71.91M | $3.51M | $0.09 |
| Q2 FY2025ended Jun 30, 2025 | $63.06M | $3.16M | $0.08 |
| Q1 FY2025ended Mar 31, 2025 | $59.13M | $2.63M | $0.06 |
| Q4 FY2024ended Dec 31, 2024 | $60.70M | $4.32M | $0.10 |
| Q3 FY2024ended Sep 30, 2024 | $58.00M | $3.88M | $0.10 |
Company profile
- Name
- Viemed Healthcare, Inc.
- Ticker
- VMD
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Services-Misc Health & Allied Services, NEC
- Headquarters
- 625 E. Kaliste Saloom Rd., Lafayette, LA 70508
- Incorporated in
- A1
- Fiscal year ends
- December
- SEC CIK
- 0001729149
Recent SEC filings
- Aug 20, 2026
- Aug 3, 2026
- Aug 3, 2026
- Jun 4, 2026
- Jun 2, 2026
- May 5, 2026
- May 5, 2026
- Mar 16, 2026
Frequently asked questions
What is Viemed Healthcare's stock price?
Viemed Healthcare (VMD) closed at $1,025.59 on Oct 9, 2026, down 0.48% from the previous close of $1,030.52.
What is Viemed Healthcare's market cap?
Viemed Healthcare's market cap is $39.06B, based on a share price of $1,025.59 and 38.1M shares outstanding as of Jun 30, 2026.
How much revenue does Viemed Healthcare make?
Viemed Healthcare reported revenue of $270.28M for fiscal 2025, up 20.52% from fiscal 2024.
What is VMD's P/E ratio?
Viemed Healthcare's price-to-earnings ratio is 2,848.9, based on trailing twelve-month diluted EPS of $0.36.
Does Viemed Healthcare pay a dividend?
Viemed Healthcare's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Viemed Healthcare, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures